Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Postgraduate Medicine
|
June 1, 1992
Clarification. Drug therapy for hyperlipidemia: when reducing cardiovascular risk is a priority
H E Bays
Drug Safety
|
November 24, 1998
Drug interactions of lipid-altering drugs
H E Bays, C A Dujovne
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques
|
January 1, 1994
Drugs for treatment of patients with high cholesterol blood levels and other dyslipidemias
H E Bays, C A Dujovne
The Medical Clinics of North America
|
November 1, 1988
Peripheral diabetic neuropathy
H E Bays, M A Pfeifer
Drugs of Today (Barcelona, Spain : 1998)
|
February 22, 2012
Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity
H E Bays, K M Gadde
Drugs in R&D
|
November 24, 1999
Lipid-altering drugs in development
H E Bays, C A Dujovne
Postgraduate Medicine
|
April 1, 1992
Drug therapy for hyperlipidemia. When reducing cardiovascular risk is a priority
H E Bays, C A Dujovne
International Journal of Clinical Practice
|
December 5, 2008
Does nicotinic acid (niacin) lower blood pressure?
H E Bays, D J Rader
International Journal of Clinical Practice
|
May 12, 2007
The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys
H E Bays, R H Chapman, S Grandy, et al.
International Journal of Clinical Practice
|
July 13, 2010
The Bile Acid Sequestrant Acceptability scale validation study
H E Bays, K C Maki, K Schmitz
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Postgraduate Medicine
|
June 1, 1992
Clarification. Drug therapy for hyperlipidemia: when reducing cardiovascular risk is a priority
H E Bays
Drug Safety
|
November 24, 1998
Drug interactions of lipid-altering drugs
H E Bays, C A Dujovne
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques
|
January 1, 1994
Drugs for treatment of patients with high cholesterol blood levels and other dyslipidemias
H E Bays, C A Dujovne
The Medical Clinics of North America
|
November 1, 1988
Peripheral diabetic neuropathy
H E Bays, M A Pfeifer
Drugs of Today (Barcelona, Spain : 1998)
|
February 22, 2012
Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity
H E Bays, K M Gadde
Drugs in R&D
|
November 24, 1999
Lipid-altering drugs in development
H E Bays, C A Dujovne
Postgraduate Medicine
|
April 1, 1992
Drug therapy for hyperlipidemia. When reducing cardiovascular risk is a priority
H E Bays, C A Dujovne
International Journal of Clinical Practice
|
December 5, 2008
Does nicotinic acid (niacin) lower blood pressure?
H E Bays, D J Rader
International Journal of Clinical Practice
|
May 12, 2007
The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys
H E Bays, R H Chapman, S Grandy, et al.
International Journal of Clinical Practice
|
July 13, 2010
The Bile Acid Sequestrant Acceptability scale validation study
H E Bays, K C Maki, K Schmitz
Page
of 2